The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 2, 2011, Pages

  Kalungi, Sam ^a,c   Wabinga, Henry ^c   Bostad, Leif ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

BL; cell cycle; RLH; Uganda

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA 2 PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOID HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE LYMPHOID HYPERPLASIA;

ADOLESCENT; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CRK-ASSOCIATED SUBSTRATE PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENDEMIC DISEASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PSEUDOLYMPHOMA; RETINOBLASTOMA-LIKE PROTEIN P130; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952190955     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181edf543     Document Type: Article

References (50)

1. Shapira J, Peylan-Ramu N. Burkitt's lymphoma. Oral Oncol. 1998;34:15-23. (Pubitemid 28210526)
2. Tumwine LK, Campidelli C, Righi S, et al. B-cell non-Hodgkin lymphomas in Uganda: An immunohistochemical appraisal on tissue microarray. Hum Pathol. 2008;39:817-823.
3. Natkunam Y. The biology of the germinal center. Hematology Am Soc Hematol Educ Program. 2007;2007:210-215.
4. Kondo E, Yoshino T. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: Insight into B-cell lymphomagenesis. Pathol Int. 2007; 57:391-397. (Pubitemid 46976406)
5. Dalla-Favera R, Bregni M, Erikson J, et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79:7824-7827. (Pubitemid 13182471)
6. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol. 2000;18:3707-3721.
7. Stewart CL, Soria AM, Hamel PA. Integration of the pRB and p53 cell cycle control pathways. J Neurooncol. 2001;51: 183-204. (Pubitemid 32479294)
8. Quelle DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83:993-1000. (Pubitemid 26006540)
9. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996;85:27-37. (Pubitemid 26116804)
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707. (Pubitemid 24036021)
11. Herman JG, Civin CI, Issa JP, et al. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 1997;57:837-841. (Pubitemid 27098005)
12. Pinyol M, Cobo F, Bea S, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood. 1998;91:2977-2984. (Pubitemid 28227549)
13. Paggi MG, Baldi A, Bonetto F, et al. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem., 1996;62:418-430. (Pubitemid 26301541)
14. Cinti C, Claudio PP, Howard CM, et al. Genetic alterations disrupting the nuclear localization of the retinoblastomarelated gene RB2/p130 in human tumor cell lines and primary tumors. Cancer Res. 2000;60:383-389. (Pubitemid 30070766)
15. Lazzi S, Bellan C, De Falco G, et al. Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: Implications for disease pathogenesis. Hum Pathol. 2002;33:723-731. (Pubitemid 34953352)
16. Klumb CE, de Resende LM, Tajara EH, et al. p53 gene analysis in childhood B non-Hodgkin's lymphoma. Sao Paulo Med J. 2001;119:212-215.
17. Dotto GP. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta. 2000;1471:M43-M56.
18. Tanaka T, Slamon DJ, Battifora H, et al. Expression of p21 ras oncoproteins in human cancers. Cancer Res. 1986;46: 1465-1470. (Pubitemid 16048297)
19. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183:10-17. (Pubitemid 30130220)
20. Baldi A, Esposito V, De Luca A, et al. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin Cancer Res. 1997;3:1691-1697. (Pubitemid 27444706)
21. Sanchez-Beato M, Saez AI, Martinez-Montero JC, et al. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: P27KIP1 expression is inversely proportional to the proliferative index. Am J Pathol. 1997;151:151-160.
22. Villuendas R, Piris MA, Orradre JL, et al. P53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol. 1992;166:235-241.
23. el-Deiry WS, Tokino T, Waldman T, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995;55:2910-2919.
24. Paik JH, Jeon YK, Park SS, et al. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas. Histopathology. 2005;47: 281-291. (Pubitemid 41243266)
25. Sahu GR, Das BR. Alteration of p73 in pediatric de novo acute lymphoblastic leukemia. Biochem Biophys Res Commun. 2005;327:750-755. (Pubitemid 40092813)
26. Susini T, Massi D, Paglierani M, et al. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol. 2001;32:360-367. (Pubitemid 32378297)
27. Kalungi S, Steine SJ, Wabinga H, et al. pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. BMC Clin Pathol. 2009;9:6.
28. Jox A, Rohen C, Belge G, et al. Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol. 1997;8(suppl 2): 131-135.
29. Xiang-Lan M, Zu-Lan S, Dan H, et al. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl Res. 2008;151:303-308. (Pubitemid 351736005)
30. Barnouin K, Fredersdorf S, Eddaoudi A, et al. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene. 1999;18: 6388-6397.
31. Villuendas R, Sanchez-Beato M, Martinez JC, et al. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol. 1998;153:887-897. (Pubitemid 28419041)
32. Bartkova J, Lukas J, Guldberg P, et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 1996;56: 5475-5483. (Pubitemid 27011383)
33. Del Valle L, Baehring J, Lorenzana C, et al. Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas. Mol Pathol. 2001;54:331-337. (Pubitemid 32928260)
34. Vousden KH. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol. 1995;6:109-116.
35. Sullivan CS, Baker AE, Pipas JM. Simian virus 40 infection disrupts p130-E2F and p107-E2F complexes but does not perturb pRb-E2F complexes. Virology. 2004;320:218-228. (Pubitemid 38315149)
36. Butel JS. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis. 2000;21: 405-426. (Pubitemid 30137926)
37. Hangaishi A, Ogawa S, Imamura N, et al. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/ p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87:4949-4958.
38. Hussein MR, Al-Sabae TM, Georgis MN. Analysis of the Bcl- 2 and p53 protein expression in the lymphoproliferative lesions in the upper Egypt. Cancer Biol Ther. 2005;4:324-328. (Pubitemid 41351294)
39. Klumb CE, Hassan R, Zalcberg IR, et al. p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas. Pediatr Blood Cancer. 2004;43: 115-119. (Pubitemid 38898718)
40. Martinez-Delgado B, Robledo M, Arranz E, et al. Correlation between mutations in p53 gene and protein expression in human lymphomas. Am J Hematol. 1997;55:1-8. (Pubitemid 27202396)
41. Wilda M, Bruch J, Harder L, et al. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Leukemia. 2004;18:584-588. (Pubitemid 38425874)
42. Pinyol M, Hernandez L, Martinez A, et al. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am J Pathol. 2000;156: 1987-1996. (Pubitemid 30641767)
43. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood. 1994;84:2412-2421.
44. Chemeris G, Loktinov A, Rempel A, et al. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Virchows Arch. 1995;426:563-569.
45. Bai M, Vlachonikolis J, Agnantis NJ, et al. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol. 2001;14:1105-1113. (Pubitemid 33063203)
46. Sanchez-Beato M, Saez AI, Navas IC, et al. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27. Am J Pathol. 2001;159: 205-213. (Pubitemid 33704205)
47. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood. 2003;101:1220-1235. (Pubitemid 36182489)
48. Kapic A, Helmbold H, Reimer R, et al. Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ. 2006;13:324-334. (Pubitemid 43102215)
49. Sanchez-Beato M, Camacho FI, Martinez-Montero JC, et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood. 1999;94:765-772. (Pubitemid 29323891)
50. Mbulaiteye SM, Walters M, Engels EA, et al. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis. 2006;193:422-426. (Pubitemid 43122342)